How many drugs were approved in 2002?

Drug Landscape tracks 40 drug approvals with a first_approval_date in 2002 (FDA, EMA, MHRA, PMDA combined). The full list is on this page, each linked to its primary regulatory source.

Which patents expired in 2002?

No tracked patents have an expiry date in 2002.

What Phase 3 readouts happened in 2002?

No Phase 3 trials have completion dates in 2002.

Where does this data come from?

Approvals from FDA Drugs@FDA, EMA EPAR, MHRA, and PMDA. Patent data from FDA Orange Book + USPTO PAIR. Trial data from ClinicalTrials.gov. Updates daily.

2002 in pharma — approvals, patent cliffs, Phase 3 readouts

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2002: 40 approvals, 0 patent expiries, 0 Phase 3 milestones.

2000 2001 2002 2003 2004

FDA / EMA / MHRA approvals (40)

2002-08-13 — Synthroid · Generic (originally multiple — AbbVie/Synthroid) · United States · Oncology
2002-08-14 — Lexapro · Generic (originally Lundbeck/Forest) · United States · Neuroscience
2002-11-15 — Abilify · Generic (originally Otsuka/BMS) · United States · Neuroscience
2003 — Factive · Lg Chem Ltd · Infectious Disease
2003 — Factive · Lg Chem Ltd · Immunology
2003 — Trovert · Pfizer · Oncology
2003 — Cubicin · Baxter · Metabolic
2003 — Revasc · Marathon Pharms Llc · Cardiovascular
2003 — Fabrazyme · Sanofi · Metabolic
2003 — GEFITINIB
2003 — FOSAMPRENAVIR CALCIUM
2003 — Emend · Merck & Co. · Oncology
2003 — ROSUVASTATIN
2003 — Elestat · AbbVie · Other
2003 — Amevive · Astellas Pharma · Immunology
2003 — Zymar · Allergan · Infectious Disease
2003 — YTTRIUM CHLORIDE Y-90
2003 — Emtriva · Gilead Sciences · Immunology
2003 — ILOPROST TROMETHAMINE
2003 — Boniva · Hoffmann La Roche · Bone
2003 — Aldurazyme · BioMarin · Metabolic
2003 — Iressa · Pfizer Inc. · Oncology
2003 — TOSITUMOMAB · Oncology
2003 — Uroxatral · Advanz · Urology
2003 — Reyataz · Bristol-Myers Squibb · Immunology
2003 — Hu1124 · Roche · Immunology
2003 — YTTRIUM CHLORIDE
2003 — Fuzeon · Roche · Immunology
2003 — ATAZANAVIR SULFATE
2003 — EPINASTINE HYDROCHLORIDE
2003 — Lexiva · GSK · Immunology
2003 — Femring · Apil · Metabolic
2003 — Namenda · AbbVie · Neuroscience
2003 — Crestor · AstraZeneca · Metabolic
2003 — Velcade · Shilpa · Oncology
2003 — Zavesca · AstraZeneca · Metabolic
2003 — Emend · Oncology
2003 — Plenaxis · Speciality European · Other
2003 — ALFUZOSIN HYDROCHLORIDE
2003 — Trovert · Pfizer · Other

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.